ARC Stock: price and insider trades · Australia

ARC is a Health Care company. Its directors and officers file their transactions with ASX. Over the twelve months to 18 October 2026, 7 filings were filed, from 5 insiders.

Every open-market trade in the period is a purchase: 3 purchases worth €100k, from 2 insiders, and not a single sale. No amount is published for 1 filing, which the totals therefore leave out. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Michael Walker filed the largest purchase, €61k, on 16 June 2026, which represents 1.9% of the company's market value. Among those who bought: 2 senior executives.

Across the 2,530 companies tracked on its exchange, the median is 3 filings; at 7 filings, this issuer sits above that mark. Looking back to 2026, when coverage begins, insiders filed 3 purchases and no sales.

The clock since the last published purchase (9 September 2026) now reads 38 days.

Elsewhere in the same sector, our signals recently picked up insider purchases at Cooper Companies, Inc. and Anixa Biosciences Inc. These figures are compiled from regulatory filings published by ASX. They describe what insiders did and are not a recommendation.